MEDIFAST INC

MED Consumer Cyclical Personal Services

MEDIFAST INC’s revenue for fiscal 2025 (year ended December 2025) was $385.8 million, down 36.0% from fiscal 2024. In the quarter to June 2026, revenue fell 27.6%, EPS fell 221.7% and free cash flow grew 115.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years; insiders bought in the last twelve months.

11.88 0.18 −1.49%
Market cap
$134.8M
P/E
0.0×
Fwd P/E
−7.4×
Dividend yield
—
F-score
4/9
Altman Z
4.46
Beneish M
n/a
Dividend safety
57/100

MEDIFAST INC (MED) P/E ratio

Alert me on P/E ratio

MEDIFAST INC has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 702× (October 2025) — the current reading is the lowest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 0.0× —
FY2024 97.9× 1,172.57%
FY2023 7.7× (14.52%)
FY2022 9.0× (39.80%)
FY2021 14.9× (33.46%)
FY2020 22.5× 35.71%
FY2019 16.6× (38.30%)
FY2018 26.8× (13.79%)
FY2017 31.1× 11.86%
FY2016 27.8× 52.93%

Quarterly newest first

Period P/E ratio Change
Jun 2026 0.0× —
Mar 2026 0.0× —
Dec 2025 0.0× —
Sep 2025 684× 1,505.37%
42 more quarters

Against its own ten years

Low 0.0× High 702×
Ten-year median 20.9×
Current reading's percentile 9

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on MED